Demand for botanical flavonoid ingredients and dietary supplement formulations supports market expansion, while ingredient traceability and quality testing remain important priorities.

ROCKVILLE, MARYLAND, October 15, 2026 — The global chrysin extract market is projected to grow from USD 899.8 million in 2026 to USD 1,643.3 million by 2036, according to the latest market report published by Fact.MR. The industry is anticipated to expand at a compound annual growth rate (CAGR) of 6.2% over the forecast period. The market recorded a value of USD 847.3 million in 2025, with projected growth reflecting demand for specialized flavonoid ingredients and their use in dietary supplement formulations.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16734

KEY MARKET TAKEAWAYS

Market Valuation: USD 899.8 million in 2026, projected to reach USD 1,643.3 million by 2036.
Growth Rate:2% CAGR from 2026 to 2036.
Leading Source Segment: Passiflora incarnata accounts for 42.1% of the market in 2026.
Leading Product Form: Powder represents 45.2% of the market.
Leading Application: Dietary supplements account for 42.3% of the market.
Fastest-Growing Country: Germany leads the five profiled country markets with a projected 7.8% CAGR.
Core Growth Driver: Interest in specialized botanical ingredients, supported by source traceability, consistent extract quality, and formulation development.
INDUSTRY SHIFTS & MARKET DYNAMICS

Demand for chrysin extract is linked to its role as a plant-derived flavonoid ingredient in dietary supplements and other specialized formulations. Manufacturers source chrysin from plants such as Passiflora incarnata and Oroxylum indicum. In 2026, Passiflora incarnata is projected to account for 42.1% of the market by source, while powder leads the form segment with a 45.2% share. Powder extracts offer practical advantages for bulk handling, measurement, and blending with other dry ingredients. Dietary supplements remain the leading application, accounting for 42.3% of market value.

Product development and ingredient verification are shaping purchasing decisions across the supply chain. Buyers increasingly need clear information about botanical origin, chrysin concentration, batch consistency, and supporting laboratory documentation. Online retail is projected to represent 38.4% of the market in 2026, giving specialist products another route to reach consumers and buyers. Suppliers that maintain consistent specifications and provide certificates of analysis can help supplement manufacturers assess ingredients before incorporating them into finished products.

However, formulation challenges remain. Chrysin has limited water solubility and low oral bioavailability, which can complicate product development and the evaluation of potential applications. Variations in botanical composition also make testing and standardization important. Safety requirements, ingredient classification, labeling rules, and limitations in clinical evidence for certain product claims can affect commercialization. Manufacturers must distinguish between ingredient research and substantiated claims for consumer products. Investment in standardized extracts, improved dispersibility, traceable sourcing, and reliable quality controls may help address these challenges.

REGIONAL MARKET SUMMARY

Fact.MR projects the following country-level growth rates for the 2026–2036 period:

Country

Projected CAGR (2026–2036)

Market Growth Context

Germany

7.8%

Botanical identity and ingredient documentation

Brazil

7.1%

Botanical ingredient processing and supplement formulation

United States

6.5%

Ingredient verification and specialist supplement development

United Kingdom

5.8%

Ingredient classification and formulation requirements

Japan

5.1%

Product-quality assessment and specialized flavonoid research

Germany is projected to record the fastest growth among these five countries, with a 7.8% CAGR. Brazil follows at 7.1%, while the United States is forecast to expand at 6.5%. The United Kingdom and Japan are projected to register CAGRs of 5.8% and 5.1%, respectively.

These forecasts reflect differing market conditions and product-development priorities. Across the countries assessed, ingredient quality, botanical sourcing, formulation requirements, and applicable regulatory considerations remain relevant to commercial adoption.

ANALYST INSIGHTS

“Customers often look for clear information on an ingredient's source and consistent product quality. Suppliers that provide reliable sourcing details and maintain the same quality across batches make it easier for buyers to evaluate the ingredient before considering any product claims,” stated Shambhu Nath Jha, Principal Consultant at Fact.MR.

“Opportunities exist for suppliers that can deliver standardized extracts, dependable batch documentation, and ingredients suited to specific formulation requirements. Clear distinctions between botanical extracts, ingredient specifications, and substantiated product claims will remain important as manufacturers evaluate new applications.”

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/report/chrysin-extract-market

FREQUENTLY ASKED QUESTIONS

Q: What is the projected size of the chrysin extract market by 2036?

A: The market is estimated at USD 899.8 million in 2026 and is projected to reach USD 1,643.3 million by 2036, growing at a CAGR of 6.2%.

Q: Which source segment holds the leading market share?

A: Passiflora incarnata is projected to hold the leading source position, accounting for 42.1% of the market in 2026.

Q: Which product form leads the chrysin extract market?

A: Powder is projected to account for 45.2% of the market in 2026, supported by its suitability for bulk handling and controlled ingredient blending.

Q: Which application represents the largest share?

A: Dietary supplements are projected to account for 42.3% of the market in 2026.

Q: Which country exhibits the highest projected growth rate?

A: Germany is projected to lead the five profiled country markets, with a CAGR of 7.8% from 2026 to 2036.

Q: What are the major challenges facing the market?

A: Limited water solubility, low oral bioavailability, variation in botanical composition, safety and labeling requirements, and limitations in clinical evidence for certain claims can complicate product development and commercialization.

Q: Which companies are profiled in the report?

A: The report profiles Purecium Limited, Botanical Cube Inc., Sabinsa Corporation, Chengdu Biopurify, Xi’an Kintai Biotech Inc., and Shaanxi Greenyo Biotech Co., Ltd.

Explore More Related Studies Published by Fact.MR Research

Oat Oil Market- https://www.newstrail.com/oat-oil-market-to-reach-usd-130-38-million-by-2036-india-cagr-7-6-china-cagr-7-5-germany-cagr-5-9/

Pygeum Bark Extract Market- https://www.newstrail.com/pygeum-bark-extract-market-to-reach-usd-595-7-million-by-2036-germany-cagr-8-2-brazil-cagr-7-5/

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.

Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: [email protected]
Phone: +1 (628) 251-1583
Website: www.factmr.com